ARCHIVES

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

This article is from The Cancer Letter archive.

Vol. 16 No. 15 | April 13, 1990

Download PDF Visit The Full Archive

Related Articles

Advisory Groups: Nominations Sought For Director’s Consumer Liaision Group

June 13, 1997

Progress Reported On Zinder Recommendations for Virus Program

July 4, 1975

NCI-Approved Clinical Trials

December 31, 2004

Regulatory Agencies: FDA Proposes “Treatment IDE” Funding Opportunities:

February 7, 1997

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

Dana-Farber Accepts Responsibility For Death Of One Patient, Harm To Another

March 31, 1995